| Literature DB >> 32923570 |
Meagan M Simpson1, Edward W Cowen2, Sunghun Cho3.
Abstract
Entities:
Keywords: acral petechiae; acral rash; dermatitis herpetiformis; gluten sensitivity; petechial rash; vibices
Year: 2020 PMID: 32923570 PMCID: PMC7475064 DOI: 10.1016/j.jdcr.2020.07.032
Source DB: PubMed Journal: JAAD Case Rep ISSN: 2352-5126
Fig 1Acral petechiae on the lateral aspect of the right index finger were present for approximately 1 year in patient 1 (A). Petechiae following dermatoglyphs on the lateral aspect of the right index finger in patient 2 (B).
Fig 2Arcuate, red and brown macules superior to a violaceous, dermal papule on the right palm and volar aspect of the wrist (A) in patient 3. The same patient had petechiae on the thumb, with 2 superior lesions tracking along dermatoglyphs (B).
Fig 3Punch biopsy from the finger of patient 3 demonstrated dense neutrophilic aggregates in the dermal papillae, superficial dermal edema, and dermal hemorrhage on hematoxylin-eosin staining (left). Direct immunofluorescence demonstrated granular IgA deposits in the dermal papillae, consistent with dermatitis herpetiformis (right).
Differential diagnosis for primary acral purpura and petechiae
| Category | Cause | Evaluation | Further considerations |
|---|---|---|---|
| Inflammatory | Dermatitis herpetiformis | Skin biopsy, DIF | Usually personal or family history of gluten intolerance or celiac disease |
| Vasculitis | Small vessel | Skin biopsy, DIF | Primary hypercoagulable states, |
| Embolic | Bacterial endocarditis | Skin biopsy | Admit for endocarditis evaluation |
| Infectious | Gonococcemia | Skin biopsy | Admit for IV antibiotics supportive care |
| Trauma | Trauma | Thorough history | Chemotherapy, thrombocytopenia, anticoagulant use can predispose |
ANA, Anti-nuclear antibody; ANCA, anti-neutrophil cytoplasmic antibody; ASO, antistreptolysin O; CBC, complete blood count; CMP, complete metabolic panel; DIF, direct immunofluorescence; DM, dermatomyositis; ECHO, echocardiogram; IV, intravenous; RA, rheumatoid arthritis; RMSF IFA, Rocky Mountain spotted fever indirect immunofluorescence; SLE, systemic lupus erythematosus; tTG3, tissue transglutaminase 3.
Primary hypercoagulable states include factor V Leiden, prothrombin gene mutation; protein C/S, antithrombin III deficiency; and antiphospholipid antibody, hyperhomocysteinemia.
Rocky Mountain spotted fever indirect immunofluorescence result is typically not positive until antibodies develop weeks after the onset of symptoms, so empirical treatment initiation is based on clinical diagnosis.